News
Desguaces y Chatarras Pedrós renews with the IRBLleida
To promote biomedical research in Lleida
Solutioma renews its collaboration with IRBLleida
To promote biomedical research in Lleida
A clinical trial led from Lleida uses oral iron molecules in large people with heart failure
The PREFER trial has been recognised as innovative for using oral iron molecules and targeting a particularly vulnerable population: large people with advanced heart disease, usually excluded from other trials
Refisa renews its collaboration with IRBLleida
To promote biomedical research in Lleida
Dermatologists from Lleida participate in the campaign Euromelanoma 2025 with free reviews
This is a European initiative on prevention and early diagnosis of skin cancer
Invelon renews its collaboration with IRBLleida
To promote biomedical research in Lleida
